Boston · Seed–Series C · 8 people tracked
Also known as CHTP MANAGEMENT SERVICES INC. · CHV MANAGEMENT, LLC
Investment thesis
CHV invests in early-stage MedTech companies developing breakthrough medical technologies that address significant clinical needs with meaningful market potential. It looks for visionary teams with strong technological foundations, clear regulatory pathways, and scalable, capital-efficient business models. The firm typically leads or co-leads initial investments and continues to participate in follow-on rounds through exit, adding value beyond capital via mentorship, industry connections, and hands-on operational guidance rooted in a deep MedTech network built over more than a decade.
Source: firm website, verified Aug 25, 2026.
Team · 8 people
from the firm's website
What they invest in
from 9 of 18 portfolio companiesHealthtech ×9Medical Devices ×6Biotech ×5Digital Health ×3FemTech ×2AI & Machine Learning ×1B2B Marketplaces ×1IoT ×1
HQs:United States×9Germany×1
Investments · 18 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 12020 · 12016 · 12015 · 12014 · 17 dated
AngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes.
HealthtechMedical DevicesLatham, US
Jim Clemmer(President, Chief Executive Officer, and Director)Steve Trowbridge(Executive Vice President and Chief Financial Officer)Chad Campbell(Senior Vice President and General Manager, Oncology and Interventional Devices)Marna Bronfen-Moore(Senior Vice President, Human Resources)Larry Weiss(Senior Vice President, Chief Legal Officer, and Corporate Secretary)Benjamin Davis(Senior Vice President, Corporate Development and Strategy)
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.
BiotechDigital HealthFemTechHealthtechSalt Lake City, US
Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)Gregory C. Critchfield(Executive Officer, Director)Andrew A. Sauter(Executive Officer)Richard L. Novak(Director)
BoardMansoor Mirza(Director)
Co-investorsaMoonExcelestar VenturesOUP (Osage University Partners)UpStart VenturesVivo CapitalDomain Associates
Toronto
Sara G. Lewis(Director)Dean A. Connor(Executive Officer, Director)James H. Sutcliffe(Director)William Anderson(Director)Real Raymond(Director)Krystyna T. Hoeg(Director)
Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Julie Brooks(Executive Officer)Samuel D. Colella(Director)Shelly D. Guyer(Executive Officer)Fred E. Cohen(Director)Brian G. Atwood(Director)Evan Jones(Director)
Co-investorsKleiner Perkins
Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOrange County, US
Alaina Brinley Rajagopal, MD PhD(Founder)inAditya Rajagopal(Co-founder & CEO)Alaina Brinley Rajagopal(Co-founder & CMO)Yaser Abu-Mostafa(Co-founder)Lynne Rollins(Chief Financial Officer)Raymond Jimenez(Chief Technology Officer)
Co-investorsBold Capital PartnersFREEFLOWMaverick VenturesWavemaker Three-Sixty Health
PanTher develops targeted cancer therapeutics that deliver drugs directly to tumor sites at high concentrations over extended periods, aiming to improve clinical outcomes while reducing side effects.
BiotechHealthtechMedical DevicesAustin, US
Laura Indolfi(Chief Executive Officer and Co-Founder)Elazer Edelman(Director)
BoardD Mackey(Director)Daniel Wildman(Director)Darshana Zaveri(Director)Maria Palasis(Director)
Co-investorsAngel Physicians FundMission BiocapitalWalnut Venture Associates
Wakefield, US
BoardJoshua S. Phillips(Executive Officer, Director)inPeter Kolchinsky(Director)in
Board seatDarshana Zaveri· per SEC Form D · $500K raise · filed Nov 2016
Co-investorsRA Capital
Co-investorsAccess Venture PartnersAdit Ventures Management, LlcAgilitas Private EquityAlba Infra PartnersALIVE Israel HealthTech FundAlkemi Growth Capital+73 more
BiotechHealthtechSt. Paul, US
Joshua Woolley(Executive Officer)Ryan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)Peter DeLange(Executive Officer)Karl Vollmers(Executive Officer)
Co-investorsAngel Physicians FundBrightstone Venture CapitalBroadview VenturesPortfoliaXeraya Capital
Co-investorsArboretum VenturesBayMed Venture PartnersBroadview VenturesHatteras Venture Partners
Avive develops automated external defibrillators (AEDs) and cardiac emergency response systems designed to improve outcomes for sudden cardiac arrest.
Digital HealthHealthtechIoTMedical DevicesForsyth, US
Rory Beyer(Co-founder)Moseley Andrews(Co-founder)Sameer Jafri(Co-founder)
Co-investorsAngel Physicians FundHealthtech CapitalIrishAngelsLaerdal Million Lives FundQuesta CapitalRC Capital+1 more
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)
Co-investorsAbstract VenturesArtis VenturesJ12 VenturesAccompliceCosmic Venture PartnersFELIX CAPITAL+11 more
Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.
BiotechFemTechHealthtechMedical DevicesBedford, US
AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)NICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)
BoardTARA BUTLER(Executive Officer, Director, Promoter)
Co-investorsAscension VenturesClavystBioDelos CapitalFemHealth VenturesIyengar Capital PartnersAmed Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 6
IPOs and acquisitions across the tracked portfolioAgilent TechnologiesNYSE: AAngioDynamicsNASDAQ: ANGOBoston ScientificNYSE: BSXSera PrognosticsNASDAQ: SERASun Life FinancialNYSE: SLFVeracyteNASDAQ: VCYT
Portfolio news
latest coverage across their companiesCure · beautyindependent.com · Aug 20, 2026
Sera Prognostics · news.alphastreet.com · Aug 20, 2026
AngioDynamics · investing.com · Aug 11, 2026
Rejoni · femtechinsider.com · Jul 1, 2026
Esperto Medical · boldcapitalpartners.com · Mar 4, 2025
Frequently asked questions
- How many investments has Catalyst Health Ventures made?
- Catalyst Health Ventures has 10 tracked investments.
- What stage does Catalyst Health Ventures invest at?
- Catalyst Health Ventures invests at the Seed, Series A, Series B, Series C stages.
- What is Catalyst Health Ventures's typical check size?
- Catalyst Health Ventures typically writes checks of $1M – $3M.
- What sectors does Catalyst Health Ventures focus on?
- Catalyst Health Ventures focuses on Digital Health, Healthtech, Medical Devices.
- Where is Catalyst Health Ventures located?
- Catalyst Health Ventures is headquartered in Boston, US.
- Does Catalyst Health Ventures lead rounds?
- Yes, Catalyst Health Ventures leads investment rounds.
- Who does Catalyst Health Ventures co-invest with?
- Catalyst Health Ventures most often shares deals with Arboretum Ventures, BayMed Venture Partners, Broadview Ventures, among 4 tracked co-investors.
Media · Podcasts & interviews
featuring the team479th 1Mby1M Entrepreneurship Podcast With Darshana Zaveri, Catalyst Health Ventures
1Mby1M Roundtables · Darshana Zaveri
Darshana Zaveri, Managing Partner at Catalyst Health Ventures - Top Healthcare Investor
Top Startup Series · Darshana Zaveri
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.